
"I am glad that taking part in a trial might help others on their own cancer journey.”
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This is a phase 2 trial. The team need up to 60 people to join the trial.
There are 2 stages of treatment in this trial.
Stage 1
Everyone has ibrutinib and rituximab for up to 7 weeks.
You then have a CT scan to see how well the treatment is working.
Stage 2
What treatment you have in this stage depends on how well the treatment in stage 1 worked for you.
If treatment worked well, you continue with ibrutinib and rituximab.
If it worked a little bit or didn’t work you have ibrutinib and R-CHOP.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Tobias Menne
Bloodwise
Janssen
University of Birmingham
Freephone 0808 800 4040
"I am glad that taking part in a trial might help others on their own cancer journey.”